This page presents strong biopharma domain names for the next frontier in affordable medicine: biosimilars and other follow-on biologics. Like the introduction of generics in the past, the current movement to expand access to biosimilars may herald significant savings for patients, insurers and other prescription drug payers.

Given the growing interest in probiotics, this page also presents a memorable marker for a microbiome enterprise based in any major metropolitan area: MetroBiome. (BuyNow)  (BuyNow)  (BuyNow)  (BuyNow)  (BuyNow)  (BuyNow)  (BuyNow)

Please also see our Anti-Aging, IoT and New Drug Trial categories. You can find a searchable list of all domain names featured on this site at our A to Z Index.